Injectable Filling Line for Sale in Uganda (2026)

No injectable filling line has ever been manufactured in Uganda. Every used, refurbished, or modular line on offer to a Ugandan buyer is an import, and the domestic buyer list is short. The anchor is Abacus Parenteral Drugs, whose 11,500 square metre blow-fill-seal plant at Mukono fills IV fluids, sterile water for injection, and other injectables at regional scale.

This guide covers what “for sale” honestly means for sterile filling equipment in this market: who is buying, where used and modular lines actually come from, why the qualification burden matters more than the sticker price, and what a line costs to land in Kampala.

Who is actually in the market for a filling line in Uganda

Three tiers, and only one of them is buying sterile equipment on a schedule.

Abacus Parenteral Drugs is the working anchor. Its Mukono site runs blow-fill-seal technology, forming, filling, and sealing containers in a single stage. Expansion there means more BFS machines, autoclaves, water-for-injection loops, and pure steam capacity rather than conventional vial fillers. Any seller of sterile utilities or BFS kit should treat this one account as the market’s centre of gravity.

Dei BioPharma’s campus at Matugga is the forward pipeline, and it should be labelled exactly that. When Parliament’s health committee reviewed the project in August 2026, about 70 percent of the works were finished, six facilities were producing around nine generic medicines, and the company put its remaining need at USD 430 million to complete construction and buy equipment, with a completion target before the end of 2027 if financing lands on time. The injectables and vaccines phases are financing-dependent. Track them, quote them, but do not book revenue against them.

The oral-dose tier is not a sterile buyer today. Quality Chemical Industries at Luzira, whose majority stake Cipla sold to Africa Capitalworks in November 2023, makes WHO-prequalified oral HIV and malaria treatments, and the generics plants around Kampala press tablets and fill syrups. If one of them adds a first small-volume parenteral suite, it will almost certainly be a modular buy, not a used high-speed line.

The demand logic behind all three tiers is import substitution. Uganda still imports about 90 percent of the medicines it consumes, and the sector-wide picture of plants, offtake, and policy sits in our Uganda pharma and medical manufacturing guide. Customs, banking, and tender mechanics across every sector are mapped in the Uganda industrial procurement guide.

What the used and modular market actually offers

A conventional injectable line is a train: container washing, a depyrogenation tunnel, the aseptic filler and stoppering station, capping, and inspection, wrapped in a RABS or isolator with matching cleanroom HVAC.

Used trains reach the market through four channels. Specialist auctioneers and marketplaces such as Federal Equipment and EquipNet clear surplus from plant closures and biotech liquidations. OEM refurbishment programmes at Syntegon, Bausch+Strobel, IMA Life, Optima, and Groninger rebuild and resell their own machines with warranty and a clean parts path. Direct plant-to-plant transfers carry the best documentation but are hard to time. Modular suppliers sell factory-tested skid or isolator suites that validate fastest of all.

Uganda adds a twist the open market rarely prices in. Because the installed sterile base is blow-fill-seal, a “used injectable filling line” for the incumbent buyer means a BFS machine, and BFS machines seldom appear at auction. They mostly change hands refurbished through the builder. A seller pushing a used vial filler at the one plant that runs BFS is answering a question nobody in Mukono asked.

One ownership note for anyone specifying freeze-dried product: lyophilisation specialist Telstar has been part of Syntegon since October 2024, so a used Telstar unit now routes to Syntegon for parts and rebuild support.

The qualification burden is the real price

Here is the honest part of any used-sterile pitch. A filler that ran compliantly in Europe has no regulatory standing on a Ugandan floor until it is requalified there. Relocation triggers installation and operational qualification regression, then performance qualification, then media fills under worst-case interventions. The benchmark is EU GMP Annex 1, in operation since August 2023, which demands a documented contamination control strategy and tighter isolator and RABS expectations than the standard most used lines were built to. An older open-RABS unit may need a barrier retrofit before it can pass. That cost belongs in the purchase decision, not after it.

The Ugandan layer on top: the National Drug Authority licenses manufacturing sites and inspects to GMP, and under the reform passed by Parliament in March 2026 it is being reconstituted as the National Drug and Health Products Authority. A used line with a complete validation history feeds straight into the site licence file. A bargain filler with no documentation can stall that licence for months, which is why the sensible Ugandan buy is the outcome, not the box: an OEM-refurbished machine or an integrator scope that includes requalification, or a pre-validated modular suite for a first line. Uganda has no deep bench of local validation contractors to rescue a badly bought asset.

Landed cost: duty, VAT, and the road from Mombasa

The fiscal side is friendlier than most sellers assume. Rates apply to customs value, and on used machinery URA may test the declared transaction value against its valuation database, so keep the auction invoice and refurbishment records together.

Charge	Rate on filling-line machinery (HS 84)
EAC CET import duty	0% (capital goods band, applies to used units too)
VAT	18%, deferrable on imported plant and machinery
Import declaration fee	1%, plant and machinery exempt under the 2025 external-trade amendments
Infrastructure levy	1.5%, same machinery exemption applies

The VAT deferment is worth structuring for. VAT on imported plant and machinery can be deferred rather than paid at the border, and URA requires the discharge application within 28 days after the deferment period ends, with a physical inspection of the installed machinery. On a seven-figure line, that is real working capital.

Freight is the harder line item. Uganda is landlocked. A line ships as crated sub-assemblies to Mombasa, clears, then trucks 3 to 7 days up the Northern Corridor through Malaba. The standard gauge railway on that corridor is under construction, not operating, so plan on road for any delivery in the next few years. Sterile equipment does not forgive rough handling: specify shock and tilt loggers on the filler and isolator crates, insure against programme delay as well as physical damage, and fly sensitive change parts and instruments into Entebbe.

How these purchases get paid

Payment mechanics split by channel. An auction or marketplace purchase is usually cash against documents with little performance recourse, which is exactly why the diligence has to happen before the hammer, not after. OEM-refurbished and modular scopes run on normal capital-goods terms: letters of credit through Stanbic, Absa, Standard Chartered’s corporate desk, dfcu, or Centenary, with European or Gulf confirmation on larger tickets. Export credit cover follows the flag on the kit, SACE on Italian scope, Euler Hermes on German, Sinosure on Chinese utilities and packaging.

The shilling itself is not the problem. The UGX floats with Bank of Uganda smoothing and has traded in a band of roughly 3,458 to 3,788 per dollar through 2026, with no FX rationing on capital-goods imports. Expect Ugandan buyers to anchor the final payment tranche to qualification sign-off rather than delivery, a habit that applies to refurbished equipment just as firmly as to new.

Where the sellers and buyers actually meet

The conventional meeting points serve this equipment line badly, which matters to a buyer trying to find credible sellers as much as to a vendor hunting buyers. The Uganda International Trade Fair at UMA’s Lugogo grounds in Kampala draws consumer and general industrial exhibitors, not asset managers with surplus aseptic fillers. Propak East Africa in Nairobi is the regional show Ugandan processing and packaging buyers attend, but sterile process equipment is a sideline there. The machines themselves trade at Achema in Frankfurt and through the auction houses, rooms where Ugandan production directors rarely stand.

The Kampala importer-distributor channel does not bridge the gap either. Those firms move Indian and Chinese consumables, APIs, and spares efficiently, and a capital sterile line does not fit their economics. A Nairobi-based field rep covering Uganda part-time reaches one account well and misses the rest. In practice, used-line deals in this market start with a direct conversation between the plant owner and the seller or refurbisher, then move to a factory acceptance test at origin.

Send us your spec

If you are sourcing a used, refurbished, or modular injectable filling line into Uganda, send the container format, target throughput, product list, and any drawings through our contact page or directly to burak@papaverai.com. We will give you a procurement-side read on which channel fits, what the requalification gap looks like against Annex 1, and what the line costs landed in Kampala.

For equipment vendors and asset managers: the Ugandan sterile buyer set is small enough to work by name, and we run verified multi-language outbound into exactly these accounts at USD 150 to 300 per qualified lead, a cost that compounds downward as account intelligence builds. See how the engine works.

FAQ

Is a used vial filling line cheaper than a new one once it is running in Uganda?

Only if the validation history travels with it. Add requalification, media fills, any Annex 1 barrier retrofit, ocean and corridor freight, and insurance to the hammer price before comparing. A documented OEM-refurbished machine at a higher sticker often lands cheaper than an undocumented auction unit that stalls site licensing.

Does Uganda’s drug regulator have to approve the equipment itself?

No. The National Drug Authority, being reconstituted as the National Drug and Health Products Authority under the March 2026 law, licenses the manufacturing site and inspects to GMP. The equipment’s qualification file becomes evidence in that site licence, which is why an undocumented used line carries a licensing risk on top of the technical one.

Do the duty exemptions apply to second-hand machinery?

Yes. The EAC CET zero rate on capital goods follows the HS heading, not the age of the machine, and the VAT deferment on imported plant and machinery is available to VAT-registered manufacturers. Expect URA to scrutinise the declared value of used units, so keep the purchase and refurbishment paperwork consistent.

Should a first-time sterile producer in Uganda buy used or modular?

Usually modular. A factory-tested, pre-validated fill suite ships with its documentation, validates fastest, and matches the small-batch volumes a first Ugandan parenteral line realistically serves. Used high-speed trains from plant closures suit experienced sterile operators with validation teams, a profile only the established parenteral incumbent currently fits.